IL17A and hepatocellular carcinoma: The data in Fig. 3H indicated that the proportion of CD4+IL-17+ Th17 cells was significantly higher in the HCC groups of various tumor sizes than in the control group; moreover, the proportion of CD4+IL-17+ Th17 cells was significantly higher in the HCC group with a large tumor size than in the HCC group with a small tumor size.